By Michael Susin
Haleon PLC said Thursday that organic revenue for the third quarter rose, driven by increased pricing and higher volumes.
The consumer-healthcare business, which was spun out of GSK PLC and is partly owned by Pfizer Inc., reported a 10% rise in revenue for the quarter to 2.89 billion pounds ($3.28 billion). For the nine-month period, revenue rose 14% on year to GBP8.08 billion.
- Advertisement -
“Respiratory performance was strong given sustained incidences of Covid and cold and flu combined with successful innovation”, it added.
Haleon–which houses Sensodyne toothpaste and Aquafresh mouthwash as well as over-the-counter medicines Panadol and Advil–upgraded its full-year guidance and currently expects organic revenue growth to be in the range of 8% and 8.5% compared with a previous range of between 6% and 8%.
Its margin of adjusted operating profit–which strips out exceptional and other one-off items is currently expected to be slightly above last year’s margin of 22.8%, driven by positive foreign-exchange movements.
GSK owns 13.5% of Haleon, while Pfizer owns 32%.
Write to Michael Susin at email@example.com